Inflammation is one of the body’s most important defense systems. When the body is injured or exposed to harmful pathogens, inflammation helps protect tissues, remove damaged cells, and begins the healing process. However, when inflammation becomes excessive or long-lasting, it can contribute to chronic disease and tissue damage.
Chronic inflammation plays a role in many conditions, including autoimmune disease, inflammatory bowel disease, arthritis, liver disease, respiratory illness, and neurodegenerative disorders. Because inflammation is involved in so many different disease processes, researchers continue to study therapies that may help regulate the immune response while also supporting tissue repair.
In this review published in Frontiers in Immunology, researchers examined the growing role of umbilical cord mesenchymal stem cells, also known as UC-MSCs, in inflammation-related diseases. The article focused on how UC-MSCs may help regulate inflammation through several connected biological mechanisms.
Why UC-MSCs Are Being Studied
Umbilical cord mesenchymal stem cells are stem cells derived from Wharton’s jelly, a tissue found within the umbilical cord. These cells are widely studied in regenerative medicine because they have strong self-renewal ability, multilineage differentiation potential, and immunomodulatory properties.
One reason UC-MSCs are especially interesting is that they do not appear to work through only one pathway. Instead, researchers describe them as having a “modular” effect, meaning they may influence several parts of the immune and repair process at the same time.
According to the review, UC-MSCs may support inflammation regulation through three main mechanisms:
- Immune cell reprogramming
- Inflammasome inhibition
- Intercellular communication
Together, these mechanisms may help shift the body away from excessive inflammation and toward a more balanced, repair-focused environment.
Immune Cell Reprogramming
One of the most important ways UC-MSCs may help regulate inflammation is by influencing immune cells. In chronic inflammatory conditions, immune cells can become overactive and continue sending inflammatory signals even after the body no longer needs them.
The review explains that UC-MSCs may help calm this response by affecting T cells, macrophages, and other immune cells involved in inflammation.
For example, UC-MSCs may help:
- Reduce overactive T cell responses
- Support regulatory T cells, also called Tregs
- Encourage anti-inflammatory immune activity
- Influence macrophage behavior
- Help restore balance between inflammatory and regulatory immune signals
This is important because many autoimmune and inflammatory diseases involve an imbalance in immune activity. By helping guide immune cells toward a more regulated state, UC-MSCs may support a healthier inflammatory response.
Inflammasome Inhibition
Another major focus of the review is inflammasome inhibition. Inflammasomes are protein complexes inside cells that help activate inflammatory responses. One of the most studied inflammasomes is called NLRP3.
When the NLRP3 inflammasome becomes overactive, it can contribute to excessive inflammation and tissue damage. The review describes how UC-MSCs and UC-MSC-derived exosomes may help reduce activation of inflammatory pathways linked to the NLRP3 inflammasome. In simpler terms, UC-MSCs may help “turn down” certain internal inflammation signals that can become too active in chronic disease.
This effect may be important for conditions where inflammation and oxidative stress continue to damage tissues over time. By helping reduce inflammasome activity, UC-MSCs may support a more controlled immune response and help protect surrounding tissues.
Intercellular Communication
UC-MSCs also appear to support healing through communication with other cells. One of the main ways they do this is through exosomes and secreted factors.
Exosomes are tiny particles released by cells that carry biological messages such as proteins, RNA, microRNAs, and growth-related signals. These messages can influence how other cells behave.
The review explains that UC-MSC-derived exosomes may help regulate inflammation, support tissue repair, and improve communication between cells in damaged or inflamed areas.
UC-MSCs may also communicate through direct cell-to-cell interactions, including the transfer of mitochondria. Mitochondria are responsible for producing energy inside cells. When damaged cells receive healthier mitochondria, they may be better able to recover and function.
Through these communication pathways, UC-MSCs may help support:
- Tissue repair
- Cell survival
- Anti-inflammatory signaling
- Blood vessel formation
- Cartilage support
- Immune balance
- Recovery in damaged tissue environments
This ability to communicate with damaged or inflamed tissue is one reason UC-MSCs continue to be studied across multiple areas of regenerative medicine.
Clinical Research in Inflammatory Diseases
The review also summarized clinical research involving UC-MSCs in several inflammation-related diseases. These include conditions such as inflammatory bowel disease, COVID-19-related lung inflammation, osteoarthritis, rheumatoid arthritis, graft-versus-host disease, liver disease, lupus, and allergic rhinitis.
Across these conditions, researchers are interested in UC-MSCs because inflammation often plays a major role in disease progression. UC-MSCs may be valuable because they can influence immune regulation and tissue repair at the same time.
The article noted that many clinical trials involving UC-MSCs are currently in early phases, but the growing number of studies shows strong interest in this area of research. The review also reported that UC-MSCs have shown a favorable safety profile across many studies, with transient fever being one of the most commonly reported reactions.
Some studies discussed in the review reported improvements in disease activity scores, inflammatory markers, pain, function, or quality of life depending on the condition studied. These findings support continued investigation into UC-MSCs as a regenerative medicine approach for inflammation-related diseases.
Why This Research Matters
Inflammation is complex. In many chronic diseases, it is not caused by one simple pathway. Instead, multiple immune cells, signaling molecules, oxidative stress pathways, and tissue repair mechanisms are involved at the same time.
This is why UC-MSCs are so interesting to researchers. Rather than focusing on one inflammatory signal, UC-MSCs may support immune balance through several mechanisms at once.
The review describes UC-MSCs as a multifunctional approach because they may help:
- Regulate immune cell activity
- Reduce inflammatory signaling
- Support tissue repair
- Release helpful exosomes
- Improve cellular communication
- Influence oxidative stress pathways
- Promote a more balanced immune environment
This broader activity may make UC-MSCs especially relevant for diseases where inflammation and tissue damage occur together.
Moving Toward More Personalized Regenerative Medicine
The review also discussed the future of UC-MSC therapy. As the field continues to develop, researchers are working to improve how UC-MSCs are produced, tested, delivered, and monitored.
Future research may focus on:
- Standardizing cell quality
- Improving dosing strategies
- Identifying the best delivery routes
- Developing engineered exosomes
- Using biomarkers to track response
- Personalizing treatment based on inflammatory activity
- Improving long-term follow-up
These steps are important because regenerative medicine depends not only on promising biology, but also on consistency, safety, and careful clinical study.
The authors emphasized that UC-MSCs and their derivatives may continue moving from exploratory research toward more standardized clinical applications as evidence grows.
A Promising Area of Inflammation Research
Umbilical cord mesenchymal stem cells represent an exciting area of regenerative medicine research because of their ability to influence inflammation from multiple angles. Their effects on immune cell behavior, inflammasome activity, exosome signaling, and tissue repair make them a strong focus for inflammatory and autoimmune disease research.
While more clinical research is still needed to better define treatment protocols and long-term outcomes, this review highlights the growing potential of UC-MSCs as a supportive tool for immune balance and tissue repair.
As scientists continue to study how UC-MSCs interact with the immune system, these cells may become an increasingly important part of future regenerative medicine strategies for chronic inflammation and inflammation-related disease.
Source
Yin L, Sun C, Chen G, Xiang Z, Hu B, Zhou F, Wang Q. Modular mastery of inflammation: umbilical cord mesenchymal stem cells as a therapeutic frontier. Front Immunol. 2025 Dec 19;16:1721947. doi: 10.3389/fimmu.2025.1721947. Available from: https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2025.1721947/full
Related Treatment Pages